SEC Form D · Amendment · filed June 1, 2022
Ambagon Therapeutics Inc
Location
SAN FRANCISCO, CA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (36)
Peter Dudek · San Francisco, CADirectorScott Clarke · San Francisco, CAExec · DirectorRoel Bulthuis · San Francisco, CADirectorAdam Rosenberg · San Francisco, CADirectorJosh Seidenfeld · San Francisco, CAExecChristian Ottmann · San Francisco, CAExecBryan Miller · San Francisco, CAExecMelissa Mccracken · San Francisco, CADirectorMargarita Chavez · San Francisco, CADirectorMichelle Arkin · San Francisco, CADirectorNancy Pryer · San Francisco, CAExecJanwillem Naesens · San Francisco, CADirectorAnthony J. Varone · Powell, OHDirectorJason B. Campbell · Cape May Court House, NJExecChristopher J. Strahl · Portland, ORExecRyan Whitney · Dayton, OHDirectorMichael O. Reinardy · Petaluma, CADirectorAlia Natafgi · Westlake, OHExecRonald E. Silva · Petaluma, CADirectorRaanan Agus · New York, NYDirectorHazem Nouraldin · Westlake, OHDirectorTarek Kteleh · Westlake, OHExec · DirectorBahram Nour-Omid · Los Angeles, CADirectorHarold Hope · New York, NYExecBlake Hylands · Toronto, Ontario, CanadaDirectorMaziyar Yousefizad · St. Petersburg, FLDirectorGeorge Xanthakys · Grand Duchy of Luxembourg, LuxembourgDirectorHyana Kim · Grand Duchy of Luxembourg, LuxembourgDirectorMichael Bell · DENVER, CODirectorCraig Weiss · Memphis, TNDirectorChris Corica · Amherst, NYExecRichard M. Ferrari · LOS GATOS, CAExecStephen H. Hochschuler · LOS GATOS, CAExec · DirectorFrank M. Fischer · LOS GATOS, CADirectorRobert K. Weigle · LOS GATOS, CAExecSteven M. Foster · LOS GATOS, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗